{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:49Z","timestamp":1790621749550,"version":"4.1.0"},"reference-count":62,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/21645515.2021.1917933","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T16:17:25Z","timestamp":1621354645000},"page":"2972-2980","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-9212","authenticated-orcid":false,"given":"Giulio","family":"Metro","sequence":"first","affiliation":[{"name":"Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Signorelli","sequence":"additional","affiliation":[{"name":"Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-1820","authenticated-orcid":false,"given":"Elio G.","family":"Pizzutilo","sequence":"additional","affiliation":[{"name":"Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giannetta","sequence":"additional","affiliation":[{"name":"Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Cerea","sequence":"additional","affiliation":[{"name":"Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Garaffa","sequence":"additional","affiliation":[{"name":"Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Friedlaender","sequence":"additional","affiliation":[{"name":"Department of Oncology, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Addeo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Mandarano","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Division of Pathology and Histology, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bellezza","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Division of Pathology and Histology, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Roila","sequence":"additional","affiliation":[{"name":"Department of Surgical and Biomedical Sciences, Medical Oncology, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/enviroments6070076"},{"key":"e_1_3_2_4_1","unstructured":"RARECARENet. [accessedMar 15]. http:\/\/rarecarenet.istitutotumori.mi.it\/fact_sheets.php."},{"key":"e_1_3_2_5_1","unstructured":"National Cancer Institute \u2013 Surveillance Epidemiology and End Results Program. [accessed Mar 15]. https:\/\/seer.cancer.gov\/csr\/1975_2017\/results_merged\/sect_17_mesothelioma.pdf."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.10.003"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.08.007"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145039"},{"key":"e_1_3_2_9_1","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Malignant pleural mesothelioma. Version 1.2021. [accessed 2021 Jan 15]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3190"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604442"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm501"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.6394"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1009285"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.269"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy086"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.03.029"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.06.022"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21113"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0000000000000177"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.012107"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.01.010"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.02.013"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.04.010"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0171"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0512-0"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1638211"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.07.015"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4883"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612074113"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.11.12"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23337"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.04.001"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.12.004"},{"key":"e_1_3_2_38_1","first-page":"1","article-title":"Second-line oral vinorelbine following first-line platinum and pemetrexed in malignant pleural mesothelioma","volume":"4","author":"S\u00f8rensen J","year":"2012","unstructured":"S\u00f8rensen J, Urbanska E, Langer S, Aamdal E. Second-line oral vinorelbine following first-line platinum and pemetrexed in malignant pleural mesothelioma. Eur J Clin Med Oncol. 2012;4:1\u20137.","journal-title":"Eur J Clin Med Oncol"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.011"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30193-1"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.009"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(13)70381-4"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00092-2"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30446-1"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.038"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-19-0103"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30765-4"},{"key":"e_1_3_2_48_1","volume-title":"Presented at: International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer","author":"Fennell D","year":"2021","unstructured":"Fennell D, Ottensmeier C, Califano R, Hanna GG, Ewings S, Kayleigh H, Wilding S, Danson S, Nye M, Steele N, et al. Nivolumab versus placebo in relapsed malignant mesothelioma: preliminary results from the CONFIRM phase 3 trial. Presented at: International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer; 2021 Jan 28\u201331. Singapore: Virtual. Abstract PS01.11."},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30169-9"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.277"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.007"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.8514"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5428"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30151-6"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.8549"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30420-X"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30462-9"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.9003"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.03.018"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1917933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:53:10Z","timestamp":1709304790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1917933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/21645515.2021.1917933"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1917933","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}